Mid-session IV Report May 21, 2019

Mid-session IV Report May 21, 2019

The following report is a snapshot of noteworthy changes in stock and option volumes, as well as changes in option implied volatilities. By monitoring this market data, traders can create strategies that capitalize on this often over looked information.

Options with increasing option implied volatility: MNK ONCE KR TSLA NRZ BKLN ADSK LB WSM VIPS

Popular stocks with increasing unusual volume: KMB KR WSM PRGO MNK KSS RIG TGT PCG BIDU GLD BABA

Tesla (TSLA) May weekly call option implied volatility is at 70, June is at 59; compared to its 52-week range of 38 to 86 after Morgan Stanley lowers ‘bear case’ valuation to $10 from $97.

Apple (AAPL) May weekly call option implied volatility is at 33, June is at 27; compared to its 52-week range of 16 to 46. Call put ratio 1.1 calls to 1 put.

Whirlpool (WHR) May weekly call option implied volatility is at 42, June is at 29; compared to its 52-week range of 22 to 49 into investor day. Call put ratio 5.7 calls to 1 put with focus on June 150 and 155 calls.

Boeing (BA) May weekly call option implied volatility is at 27, June is at 26; compared to its 52-week range of 19 to 45 after U.S. authorities increasingly think birds may have caused Boeing crash, WSJ says.

Target (TGT) 30 days IV call 32.9 -0.4%, puts 31.9 -0.9%, +10 strikes +150 contracts into EPS

Best Buy (BBY) 30 days IV call 42 -0.7%, puts 42.94 -1.2%, 20 strikes +50 contracts into EPS

Pharmaceutical-BIO’s option implied volatility into 2019 Annual Meeting of the American Society of Clinical Oncology, or ASCO

Allergan (AGN) 30-day option implied volatility is at 26; compared to its 52-week range of 19 to 42

Amgen (AMGN) 30-day option implied volatility is at 28; compared to its 52-week range of 16 to 38

Akcea Therapeutics (AKCA) 30-day option implied volatility is at 68; compared to its 52-week range 56 to 160

Ligand Pharmaceuticals (LGND) 30-day option implied volatility is at 41; compared to its 52-week range of 29 to 92

Incyte (INCY) 30-day option implied volatility is at 36; compared to its 52-week range 31 to 53

Iovance Biotherapeutics (IOVA) 30-day option implied volatility is at 77; compared to its 52-week range of 30 to 169

Pfizer (PFE) 30-day option implied volatility is at 18; compared to its 52-week range of 12 to 34

Merck (MRK) 30-day option implied volatility is at 20; compared to its 52-week range of 14 to 30

Biogen (BIIB) 30-day option implied volatility is at 28; compared to its 52-week range of 22 to 45

Eli Lilly (LLY) 30-day option implied volatility is at 22; compared to its 52-week range of 15 to 32

Gilead (GILD) 30-day option implied volatility is at 24; compared to its 52-week range of 19 to 43

Pfizer (PFE) 30-day option implied volatility is at 18; compared to its 52-week range of 13 to 34

Celgene (CELG) 30-day option implied volatility is at 15; compared to its 52-week range of 13 to 57

Bristol-Myers Squibb (BMY) 30-day option implied volatility is at 25; compared to its 52-week range of 17 to 44

Increasing unusual option volume: SSRM BCRX MNK IOVA AVYA MAC NCR PRGO HOME KSS
Increasing unusual call option volume: NCR PRGO SRE IOVA HOME
Increasing unusual put option volume: HOME MTG BCRX MNK CC VG FND LITE
Options with decreasing option implied volatility: MTG TLRY M HOME IGT IQ PINS AVYA
Active options: AAPL TSLA BAC BABA MU AMZN T AMD FB MSFT NFLX NVDA AVYA BIDU KSS QCOM MNK HD BA DIS